Patent · US Active

(Thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H1 inverse agonists/5-HT2A antagonists

US9562057B2 · kind B2 · utility

0Cited by
0References
7Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJan 8, 2014
Grant dateFeb 7, 2017
Priority date—
Expiry dateJan 8, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A dual H1 inverse agonist/5-HT2A receptor antagonist of the formula:its uses, and methods for its preparation are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.